{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:01:05Z","timestamp":1787774465647,"version":"build-2784847793"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Subcutaneous human parathyroid hormone (hPTH) therapy can effectively manage hypocalcemia in hypoparathyroidism, with varying effects on hypercalciuria. However, little is known about its ability to decrease the renal comorbidities of hypoparathyroidism: nephrocalcinosis (NC), nephrolithiasis (NL), and renal insufficiency. Urinary citrate (Ucit) promotes the solubility of urinary calcium (UCa); hypocitraturia is a risk factor for NC\/NL. Twenty-four\u2013hour UCa, Ucit, and UCa\/Ucit were determined in 31 hypoparathyroid subjects receiving hPTH 1-34 therapy for up to 5 years. Before hPTH 1-34, the geometric least squares mean UCa was 346\u2009mg\/day (normal &amp;lt;250) and Ucit was 500\u2009mg\/day (normal 250\u20131190); UCa\/Ucit was 0.67\u2009mg\/mg. After 6 months of hPTH 1-34, UCa decreased (238, p\u2009&amp;lt;\u20090.001), but with a greater decrease in Ucit (268, p\u2009&amp;lt;\u20090.001), increasing UCa\/Ucit, which became significant over time (p\u2009&amp;lt;\u20090.001). After stopping hPTH 1-34 and resuming conventional therapy (follow-up; FU), compared to the last measures on hPTH 1-34, Ucit rose to 626 (p\u2009&amp;lt;\u20090.001), reducing UCa\/Ucit to 0.44, (p\u2009&amp;lt;\u20090.05); UCa also rose (273), but was still lower than baseline (p\u2009&amp;lt;\u20090.05). Daily hPTH 1-34 dose did not correlate with UCa, but was inversely related to Ucit, and directly related to UCa\/Ucit (p\u2009&amp;lt;\u20090.01). Mean blood bicarbonate decreased significantly on hPTH 1-34 and remained lower than baseline at FU (p\u2009&amp;lt;\u20090.01). Mean eGFR increased on hPTH 1-34 (86 to 96\u2009mL\/min\/1.73\u2009m2, p\u2009&amp;lt;\u20090.001) and returned to baseline at FU. On renal imaging, 6 subjects did not have NC\/NL, 8 had NC\/NL prior to hPTH 1-34 that remained unchanged, and 16 developed new-onset (n\u2009=\u200910) or progressive (n\u2009=\u20096) NC\/NL while on hPTH 1-34. Our data demonstrate that treatment with subcutaneous hPTH 1-34 may have an untoward effect of hypocitraturia and high UCa\/Ucit ratio that may increase renal morbidity. With increasing use of PTH therapy in hypoparathyroidism, close monitoring and exploration for treatment of hypocitraturia seem warranted. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.3480","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T13:56:27Z","timestamp":1528379787000},"page":"1741-1747","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hypocitraturia Is an Untoward Side Effect of Synthetic Human Parathyroid Hormone (hPTH) 1-34 Therapy in Hypoparathyroidism That May Increase Renal Morbidity"],"prefix":"10.1093","volume":"33","author":[{"given":"Rachel I","family":"Gafni","sequence":"first","affiliation":[{"name":"Skeletal Distorders and Mineral HomeostasisNational Institute of Dental and Craniofacial ResearchNational Institutes of HealthBethesdaMarylandUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig B","family":"Langman","sequence":"additional","affiliation":[{"name":"Feinberg School of MedicineNorthwestern University and the Lurie Children's Hospital of ChicagoChicagoIllinoisUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori C","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Skeletal Distorders and Mineral HomeostasisNational Institute of Dental and Craniofacial ResearchNational Institutes of HealthBethesdaMarylandUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A","family":"Brillante","sequence":"additional","affiliation":[{"name":"Skeletal Distorders and Mineral HomeostasisNational Institute of Dental and Craniofacial ResearchNational Institutes of HealthBethesdaMarylandUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"James","sequence":"additional","affiliation":[{"name":"Rho, Inc.Chapel HillNorth CarolinaUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A","family":"Yovetich","sequence":"additional","affiliation":[{"name":"Rho, Inc.Chapel HillNorth CarolinaUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M","family":"Boyce","sequence":"additional","affiliation":[{"name":"Skeletal Distorders and Mineral HomeostasisNational Institute of Dental and Craniofacial ResearchNational Institutes of HealthBethesdaMarylandUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Collins","sequence":"additional","affiliation":[{"name":"Skeletal Distorders and Mineral HomeostasisNational Institute of Dental and Craniofacial ResearchNational Institutes of HealthBethesdaMarylandUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"issue":"10","key":"2024021014292265100_jbmr3480-bib-0001","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2024021014292265100_jbmr3480-bib-0002","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014292265100_jbmr3480-bib-0003","doi-asserted-by":"crossref","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nature Rev Dis Primers"},{"issue":"9","key":"2024021014292265100_jbmr3480-bib-0004","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024021014292265100_jbmr3480-bib-0005","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024021014292265100_jbmr3480-bib-0006","first-page":"134","article-title":"Hypocitraturia: pathophysiology and medical management","volume":"11","author":"Zuckerman","year":"2009","journal-title":"Reviews in urology"},{"issue":"3","key":"2024021014292265100_jbmr3480-bib-0007","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1152\/ajplegacy.1965.209.3.643","article-title":"Evidence for a direct effect of parathyroid hormone on urinary acidification","volume":"209","author":"Hellman","year":"1965","journal-title":"Am J Physiol"},{"issue":"160","key":"2024021014292265100_jbmr3480-bib-0008","first-page":"487","article-title":"Correction of renal bicarbonate wastage by parathyroidectomy. Implications in acid-base homeostasis","volume":"40","author":"Muldowney","year":"1971","journal-title":"Qly J Med"},{"issue":"8","key":"2024021014292265100_jbmr3480-bib-0009","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA"},{"issue":"11","key":"2024021014292265100_jbmr3480-bib-0010","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/jbmr.2555","article-title":"Transient increased calcium and calcitriol requirements after discontinuation of human synthetic parathyroid hormone 1-34 (hPTH 1-34) replacement therapy in hypoparathyroidism","volume":"30","author":"Gafni","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024021014292265100_jbmr3480-bib-0011","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1464-410X.2010.09492.x","article-title":"Laterality of nephrocalcinosis in kidney stone formers with severe hypocitraturia","volume":"107","author":"Le","year":"2011","journal-title":"BJU Int"},{"issue":"12","key":"2024021014292265100_jbmr3480-bib-0012","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ki.2011.336","article-title":"Nephrocalcinosis and urolithiasis in children","volume":"80","author":"Habbig","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"2024021014292265100_jbmr3480-bib-0013","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00467-005-1831-y","article-title":"Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation","volume":"20","author":"Stapenhorst","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2024021014292265100_jbmr3480-bib-0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000080259","article-title":"An overview of divalent cation and citrate handling by the kidney","volume":"98","author":"Unwin","year":"2004","journal-title":"Nephron Physiol"},{"key":"2024021014292265100_jbmr3480-bib-0015","doi-asserted-by":"crossref","first-page":"s1084","DOI":"10.2741\/1119","article-title":"Citrate and mineral metabolism: kidney stones and bone disease","volume":"8","author":"Caudarella","year":"2003","journal-title":"Front Biosci"},{"issue":"4","key":"2024021014292265100_jbmr3480-bib-0016","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ki.1990.265","article-title":"Renal handling of citrate","volume":"38","author":"Hamm","year":"1990","journal-title":"Kidney Int"},{"key":"2024021014292265100_jbmr3480-bib-0017","first-page":"19","article-title":"The excretion of organic anion in renal tubular acidosis with particular reference to citrate","volume":"22","author":"Dedmon","year":"1962","journal-title":"Clin Sci"},{"issue":"7","key":"2024021014292265100_jbmr3480-bib-0018","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00467-013-2420-0","article-title":"Correspondence between Ca(2)(+) and calciuria, citrate level and pH of urine in pediatric urolithiasis","volume":"28","author":"Porowski","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2024021014292265100_jbmr3480-bib-0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1203\/PDR.0b013e3181a2939e","article-title":"Urine calcium\/citrate ratio in children with hypercalciuric stones","volume":"66","author":"Srivastava","year":"2009","journal-title":"Ped Res"},{"issue":"1","key":"2024021014292265100_jbmr3480-bib-0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.juro.2007.08.163","article-title":"Urinary reference values for stone risk factors in children","volume":"179","author":"Borawski","year":"2008","journal-title":"J Urol"},{"key":"2024021014292265100_jbmr3480-bib-0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2017.03.125","article-title":"Calcium-to-citrate ratio distinguishes solitary and recurrent urinary stone forming children","author":"DeFoor","year":"2017","journal-title":"J Urol"},{"key":"2024021014292265100_jbmr3480-bib-0022","first-page":"167","article-title":"The relation between citric acid and calcium metabolism with particular reference to primary hyper-parathyroidism and idiopathic hypercalciuria","volume":"24","author":"Hodgkinson","year":"1963","journal-title":"Clin Sci"},{"issue":"2504","key":"2024021014292265100_jbmr3480-bib-0023","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.96.2504.587","article-title":"The relation between the urinary excretion of citric acid and calcium; its implications for urinary calcium stone formation","volume":"96","author":"Shorr","year":"1942","journal-title":"Science"},{"issue":"1","key":"2024021014292265100_jbmr3480-bib-0024","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF00294345","article-title":"Role of citric acid in primary hyperparathyroidism with renal lithiasis","volume":"20","author":"Alvarez-Arroyo","year":"1992","journal-title":"Urolog Res"},{"issue":"3","key":"2024021014292265100_jbmr3480-bib-0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00240-007-0096-2","article-title":"Biochemical characterization of primary hyperparathyroidism with and without kidney stones","volume":"35","author":"Odvina","year":"2007","journal-title":"Urolog Res"},{"issue":"5","key":"2024021014292265100_jbmr3480-bib-0026","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.juro.2009.01.028","article-title":"Patients with primary hyperparathyroidism\u2014why do some form stones","volume":"181","author":"Berger","year":"2009","journal-title":"J Urol"},{"issue":"2","key":"2024021014292265100_jbmr3480-bib-0027","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03345354","article-title":"Risk factors associated to kidney stones in primary hyperparathyroidism","volume":"28","author":"Corbetta","year":"2005","journal-title":"J Endocrinol Invest"}],"updated-by":[{"DOI":"10.1002\/jbmr.4522","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000}}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3480","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/33\/10\/1741\/56648684\/jbmr3480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/33\/10\/1741\/56648684\/jbmr3480.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:02:00Z","timestamp":1710342120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/33\/10\/1741-1747\/7605062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,6,7]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3480","relation":{"erratum":[{"id-type":"doi","id":"10.1002\/jbmr.4522","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10,1]]},"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"2018-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}